Sharekhan

BUY NOW Buy Trident Texofab Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Trident Texofab Ltd

Fri 11/07/2025,16:1:0

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Trident Texofab Ltd

Your Vote -

Buy

27.27%

Hold

45.45%

Sell

27.27%

27.27%

11 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Trident Texofab Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Trident Texofab - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    10 Jul 2025, 5:13PM Please find enclosed herewith the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 as received from KFin T

  • Trident Texofab - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    14 Jun 2025, 4:38PM Please find enclosed details of Voting Results and Scrutinizer's Report on the Postal Ballot\r\n

  • Trident Texofab - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

    14 Jun 2025, 4:35PM Outcome of Postal Ballot\r\n

  • Trident Texofab has submitted to BSE the Shareholding Pattern for the Period Ended June 04, 2025

    12 Jun 2025, 7:42PM As of June 2025, 32.16% is owned by Indian Promoters and 67.84% by Public. <p align=justify> Top five Promoters holding highest number of shares of Tr

  • Trident Texofab - Announcement under Regulation 30 (LODR)-Conversion of Securities

    4 Jun 2025, 6:53PM Conversion of 4,81,907 warrants into 4,81,907 equity shares of face value of Rs. 10/- each

  • Trident Texofab - Outcome Of Board Meeting Held On June 04, 2025

    4 Jun 2025, 6:50PM Conversion of 4,81,907 warrants into 4,81,907 equity shares of face value of Rs. 10/- each

  • Trident Texofab - Board Meeting Outcome for Outcome Of Board Meeting Held On June 04, 2025

    4 Jun 2025, 6:47PM Conversion of 4,81,907 warrants into 4,81,907 equity shares of face value of Rs. 10/- each

  • Trident Texofab - Announcement under Regulation 30 (LODR)-Investor Presentation

    31 May 2025, 5:51PM Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Earnings Presenta

  • Trident Texofab posts Q4 net profit of Rs 0.51 cr

    30 May 2025, 11:56AM The company reported standalone net profit during the quarter stood at Rs 0.51 crore compared to net loss of Rs 0.10 crore in the previous year quarte

  • Trident Texofab - Statement Of Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosur

    29 May 2025, 8:28PM Statement Of Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Q

  • Trident Texofab - Announcement under Regulation 30 (LODR)-Conversion of Securities

    29 May 2025, 8:22PM Conversion of 4,50,477 warrants into 4,50,477 equity shares of face value of Rs. 10/- each.

  • Trident Texofab - Appointment Of Internal Auditor

    29 May 2025, 8:20PM The Board of Directors inter-alia has approved the Appointment of Internal Auditor for the financial year 2025-26.

  • Trident Texofab - Result-Financial Result For The Quarter And Year Ended On March 31, 2025

    29 May 2025, 8:17PM Financial Result for the Quarter and year ended on March 31, 2025

  • Trident Texofab - Board Meeting Outcome for Outcome Of Board Meeting Held On May 29, 2025

    29 May 2025, 8:05PM Outcome of Board Meeting held on May 29, 2025 to consider and approve the financial result for the Quarter and year ended on March 31, 2025

  • Trident Texofab - Announcement under Regulation 30 (LODR)-Conversion of Securities

    26 May 2025, 7:34PM Conversion of 96,287 warrants into 96,287 equity shares of face value of Rs. 10/- each.\r\n

  • Trident Texofab - Outcome Of Board Meeting Held On May 26, 2025

    26 May 2025, 7:32PM Conversion of 96,287 warrants into 96,287 Equity shares of face value of Rs.10/- each.

  • Trident Texofab - Board Meeting Outcome for Outcome Of Board Meeting Held On May 26, 2025

    26 May 2025, 7:28PM Conversion of 96,287 warrants into 96,287 equity shares of face value of Rs. 10/- each.\r\n

  • Trident Texofab - Board Meeting Intimation for Considering And Approving The Audited Financial Result For Quarter And Year En

    21 May 2025, 6:32PM Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and

  • Trident Texofab has submitted to BSE the Shareholding Pattern for the Period Ended May 12, 2025

    19 May 2025, 9:32PM As of May 2025, 34.52% is owned by Indian Promoters and 65.47% by Public. <p align=justify> Top five Promoters holding highest number of shares of Tri

  • Trident Texofab - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    13 May 2025, 6:26PM Notice of Postal Ballot

  • Trident Texofab - Announcement under Regulation 30 (LODR)-Conversion of Securities

    12 May 2025, 9:18PM Conversion of 4,08,333 warrants into 4,08,333 equity shares of face value of Rs. 10/- each.

  • Trident Texofab - Outcome Of Board Meeting Held On May 12, 2025

    12 May 2025, 9:14PM Outcome of Board Meeting of the Company held on Monday, May 12, 2025 for Conversion of 4,08,333 warrants into 4,08,333 equity shares of face value of

  • Trident Texofab - Board Meeting Outcome for Outcome Of Board Meeting Of The Company Held May 12, 2025

    12 May 2025, 9:11PM Conversion of 4,08,333 warrants into 4,08,333 equity shares of face value of Rs. 10/- each.

  • Trident Texofab - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

    29 Apr 2025, 6:56PM <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'><tr> <td><b>Sr. No.</b></td

  • Trident Texofab has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    19 Apr 2025, 5:01PM As of March 2025, 35.54% is owned by Indian Promoters and 64.46% by Public. <p align=justify> Top five Promoters holding highest number of shares of T
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Trident Texofab Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 73.7359 53.2223 49.8311 48.945 41.1229
Liabilities 73.7359 53.2223 49.8311 48.945 41.1229
Equity 13.5588 10.0701 10.0701 10.0701 10.0701
Gross Profit 5.472 6.1557 6.3082 4.7851 2.8816
Net Profit 2.5101 1.0799 2.2184 0.9827 0.3531
Cash From Operating Activities -13.7077 2.7137 5.8524 1.3942 1.9591
NPM(%) 2.05 1.08 2.3 1.16 0.7
Revenue 122.0562 99.4834 96.3563 84.293 49.9264
Expenses 116.5842 93.3277 90.0481 79.5079 47.0447
ROE(%) 11.84 5.09 10.47 4.63 1.66

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Trident Texofab Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Visagar Polytex Ltd 0.88 1.15 0.00 6284.29 -6.09 0.00
India Motor Parts and Accessories Ltd 1135.05 -1.31 17.07 267.95 670.43 2.64
Mihika Industries Ltd 21.48 1.37 429.60 214.70 0.55 0.00
Hathway Cable and Datacom Ltd 15.36 -1.54 29.54 38004.05 26.13 0.00

Company Info

Brief History of the Company The Company was originally incorporated as Trident Texofab Private Limited on September 05, 2008 with the Assistant Registrar of Companies, Gujarat, Dadra and Nagar Havelli as a private limited company under the provisions of the Companies Act, 1956. Subsequently the Company was converted into public limited Company pursuant to shareholders resolution passed at the Annual General Meeting held on May 24, 2017 and the name of the Company was changed to Trident Texofab Limited. A fresh certificate of incorporation consequent upon conversion to public limited Company was issued by the Assistant Registrar of Companies, Ahmedabad on June 06, 2017. Major Events and Milestones: 2008 - Incorporation of the Company 2017 - Conversion of Private Limited Company to Public Limited Company. 2019 -Trident Texofab Commenced Commercial Production/Operations At Hojiwala, Sachin-Surat. 2020 -The Company has issued Bonus Shares in the Ratio of 14:10.

Brief History of the Company The Company was originally incorporated as Trident Texofab Private Limited on September 05, 2008 with the Assistant Registrar of Companies, Gujarat, Dadra and Nagar Havelli as a private limited company under the provisions of the Companies Act, 1956. Subsequently the Company was converted into public limited Company pursuant to shareholders resolution passed at the Annual General Meeting held on May 24, 2017 and the name of the Company was changed to Trident Texofab Limited. A fresh certificate of incorporation consequent upon conversion to public limited Company was issued by the Assistant Registrar of Companies, Ahmedabad on June 06, 2017. Major Events and Milestones: 2008 - Incorporation of the Company 2017 - Conversion of Private Limited Company to Public Limited Company. 2019 -Trident Texofab Commenced Commercial Production/Operations At Hojiwala, Sachin-Surat. 2020 -The Company has issued Bonus Shares in the Ratio of 14:10.

Read More

Parent Organisation

Trident Texofab Ltd.

Founded

05/09/2008

Managing Director

Mr.Hardik Jigishkumar Desai

NSE Symbol

FAQ

The current price of Trident Texofab Ltd is

The 52-week high for Trident Texofab Ltd is

The market capitalization of Trident Texofab Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Trident Texofab Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Trident Texofab Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Trident Texofab Ltd shares.

The CEO of Trident Texofab Ltd is Mr.Hardik Jigishkumar Desai, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT